Literature DB >> 8649858

In vivo association of ATFa with JNK/SAP kinase activities.

J L Bocco1, A Bahr, J Goetz, C Hauss, T Kallunki, C Kedinger, B Chatton.   

Abstract

The human ATFa proteins belong to the CREB/ATF family of transcription factors. We have previously shown that the ATFa proteins may contribute to the modulation of the transcriptional activity of the Jun/Fos complexes (Chatton et al. (1994). Oncogene, 9, 375-385). We now show that a protein kinase activity is strongly associated with ATFa in vivo, as revealed by coimmunoprecipitation of ATFa/kinase complexes from whole cell extracts, with antibodies against ATFa. Two independent regions were found to be implicated in kinase binding: a major interaction site is located within the N-terminal 82 residues comprising an important metal-chelating element; a weaker binding site corresponds to the basic sequence element preceding the C-terminal leucine-zipper of ATFa. Induction experiments suggest that each of these ATFa domains may interact with different kinases. The major activity is associated with the ATFa N-terminal domain. Based on its response to various inducers, on both in vitro and in vivo binding assays, and on its immunological properties, this activity most likely corresponds to the 54/55 kDa JNK2 protein. Taken together, these observations suggest that the ATFa proteins, among other CREB/ATF proteins, may be important effectors of cell signalling pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649858

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells.

Authors:  Wolfgang Breitwieser; Steve Lyons; Ann Marie Flenniken; Garry Ashton; Gail Bruder; Mark Willington; Georges Lacaud; Valerie Kouskoff; Nic Jones
Journal:  Genes Dev       Date:  2007-08-15       Impact factor: 11.361

3.  Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1.

Authors:  S H Yang; A J Whitmarsh; R J Davis; A D Sharrocks
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

4.  Ubiquitination and degradation of ATF2 are dimerization dependent.

Authors:  S Y Fuchs; Z Ronai
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif.

Authors:  S H Yang; P R Yates; A J Whitmarsh; R J Davis; A D Sharrocks
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

6.  Phosphorylation of Activation Transcription Factor-2 at Serine 121 by Protein Kinase C Controls c-Jun-mediated Activation of Transcription.

Authors:  Takahito Yamasaki; Akinori Takahashi; Jianzhi Pan; Naoto Yamaguchi; Kazunari K Yokoyama
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

7.  A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.

Authors:  Jessica Diring; Barbara Camuzeaux; Mariel Donzeau; Marc Vigneron; Manuel Rosa-Calatrava; Claude Kedinger; Bruno Chatton
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

8.  Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity.

Authors:  Pierre-Jacques Hamard; Michaël Boyer-Guittaut; Barbara Camuzeaux; Denis Dujardin; Charlotte Hauss; Thomas Oelgeschläger; Marc Vigneron; Claude Kedinger; Bruno Chatton
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.